The worldwide market for medicines is expected to exceed $1 Trillion by 2020. The emergence of global pharmaceutical companies from India, China, Brazil, Mexico and some Eastern European countries will drive the pharmaceutical industry to new horizon.  The increase in the number of companies not only increases competition in the market but may also change the way the pharmaceutical business is conducted around the world. As companies around the world strive to achieve positive growth, it will become increasingly difficult for them to create profits because of the stringent regulations, skyrocketing marketing and operational costs, availability of skilled force and ever-increasing generic competition.